{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T05:17:09Z","timestamp":1769577429964,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2019R1I1A2A01060702"],"award-info":[{"award-number":["2019R1I1A2A01060702"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Despite its clinical importance, biomarkers of disease activity in aortic stenosis (AS) are lacking. We investigated the association between anti-cyclic citrullinated peptide (CCP) antibodies and AS. All 678 patients who underwent echocardiography and anti-CCP antibody testing were analysed. Anti-CCP antibody status was categorized as negative, low-positive, and high-positive. In addition, aortic valve (AV) tissues were obtained from the patients with and without AS to analyze the presence of citrullinated proteins. At baseline, 241 (35.5%) subjects with AV degeneration had a higher rate of anti-CCP antibody positivity (42.7% versus 34.6%, p\u2009=\u20090.035) than those without AV degeneration. Out of the 331 (48.8%) subjects who underwent echocardiographic follow-up, progression of AS was observed in 34 (10.3%) patients, with a higher incidence in the high-positive group compared to the low-positive or negative group (19.0% vs. 11.3% vs. 8.4%, respectively; p\u2009=\u20090.041). On multivariable analysis, high anti-CCP antibody positivity was independently associated with progression to AS (odds ratio: 2.312; 95% confidence interval: 1.006\u20135.310; p\u2009=\u20090.048). Furthermore, immunohistochemistry and Western blotting revealed increased citrullination in diseased AV compared to normal AV tissue. This study demonstrated that a high positive anti-CCP antibody result is associated with AV degeneration and may be an independent factor for AS progression.<\/jats:p>","DOI":"10.1038\/s41598-023-36153-w","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T13:02:43Z","timestamp":1685624563000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of citrullination with the progression of aortic stenosis"],"prefix":"10.1038","volume":"13","author":[{"given":"Ah-Ram","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eunhye","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahmin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seokchan","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae-Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-Min","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duk-Hyun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Kwan","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,1]]},"reference":[{"key":"36153_CR1","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/S0140-6736(06)69208-8","volume":"368","author":"VT Nkomo","year":"2006","unstructured":"Nkomo, V. T. et al. Burden of valvular heart diseases: A population-based study. Lancet 368, 1005\u20131011 (2006).","journal-title":"Lancet"},{"key":"36153_CR2","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1016\/j.jacc.2012.02.093","volume":"60","author":"MR Dweck","year":"2012","unstructured":"Dweck, M. R., Boon, N. A. & Newby, D. E. Calcific aortic stenosis: A disease of the valve and the myocardium. J. Am. Coll. Cardiol. 60, 1854\u20131863 (2012).","journal-title":"J. Am. Coll. Cardiol."},{"key":"36153_CR3","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S0140-6736(09)60211-7","volume":"373","author":"BA Carabello","year":"2009","unstructured":"Carabello, B. A. & Paulus, W. J. Aortic stenosis. Lancet 373, 956\u2013966 (2009).","journal-title":"Lancet"},{"key":"36153_CR4","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1016\/j.biocel.2006.03.008","volume":"38","author":"B Gy\u00f6rgy","year":"2006","unstructured":"Gy\u00f6rgy, B., T\u00f3th, E., Tarcsa, E., Falus, A. & Buzas, E. I. Citrullination: A posttranslational modification in health and disease. Int. J. Biochem. Cell Biol. 38, 1662\u20131677 (2006).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"36153_CR5","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1002\/art.37961","volume":"65","author":"J Sokolove","year":"2013","unstructured":"Sokolove, J. et al. Brief report: Citrullination within the atherosclerotic plaque: A potential target for the anti-citrullinated protein antibody response in rheumatoid arthritis. Arthritis Rheum. 65, 1719\u20131724 (2013).","journal-title":"Arthritis Rheum."},{"key":"36153_CR6","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.atherosclerosis.2013.02.009","volume":"228","author":"G Cambridge","year":"2013","unstructured":"Cambridge, G., Acharya, J., Cooper, J. A., Edwards, J. C. & Humphries, S. E. Antibodies to citrullinated peptides and risk of coronary heart disease. Atherosclerosis 228, 243\u2013246 (2013).","journal-title":"Atherosclerosis"},{"key":"36153_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s12016-012-8318-y","volume":"43","author":"RA Moura","year":"2012","unstructured":"Moura, R. A., Graca, L. & Fonseca, J. E. To B or not to B the conductor of rheumatoid arthritis orchestra. Clin. Rev. Allergy Immunol. 43, 281\u2013291 (2012).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"36153_CR8","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1136\/ard.2005.049403","volume":"65","author":"D Makrygiannakis","year":"2006","unstructured":"Makrygiannakis, D. et al. Citrullination is an inflammation-dependent process. Ann. Rheum. Dis. 65, 1219 (2006).","journal-title":"Ann. Rheum. Dis."},{"key":"36153_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","volume":"43","author":"GA Schellekens","year":"2000","unstructured":"Schellekens, G. A. et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum. 43, 155\u2013163 (2000).","journal-title":"Arthritis Rheum."},{"key":"36153_CR10","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/art.20018","volume":"50","author":"MM Nielen","year":"2004","unstructured":"Nielen, M. M. et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors. Arthritis Rheum. 50, 380\u2013386 (2004).","journal-title":"Arthritis Rheum."},{"key":"36153_CR11","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1002\/art.24827","volume":"61","author":"R Aggarwal","year":"2009","unstructured":"Aggarwal, R., Liao, K., Nair, R., Ringold, S. & Costenbander, K. H. Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis. Arthritis Rheum. 61, 1472\u20131483 (2009).","journal-title":"Arthritis Rheum."},{"key":"36153_CR12","doi-asserted-by":"publisher","first-page":"102","DOI":"10.4046\/trd.2018.0091","volume":"82","author":"SH Lee","year":"2019","unstructured":"Lee, S. H. et al. Korean guidelines for diagnosis and management of interstitial lung diseases: Part 2. Idiopathic pulmonary fibrosis. Tuberc. Respir. Dis. 82, 102\u2013117 (2019).","journal-title":"Tuberc. Respir. Dis."},{"key":"36153_CR13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1471-2466-8-24","volume":"8","author":"JB Kornum","year":"2008","unstructured":"Kornum, J. B. et al. The incidence of interstitial lung disease 1995\u20132005: A Danish nationwide population-based study. BMC Pulm. Med. 8, 24 (2008).","journal-title":"BMC Pulm. Med."},{"key":"36153_CR14","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1136\/heart.89.7.801","volume":"89","author":"NM Rajamannan","year":"2003","unstructured":"Rajamannan, N. M., Gersh, B. & Bonow, R. O. Calcific aortic stenosis: From bench to the bedside\u2014Emerging clinical and cellular concepts. Heart 89, 801\u2013805 (2003).","journal-title":"Heart"},{"key":"36153_CR15","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/S0735-1097(96)00563-3","volume":"29","author":"BF Stewart","year":"1997","unstructured":"Stewart, B. F. et al. Clinical factors associated with calcific aortic valve disease cardiovascular health study. J. Am. Coll. Cardiol. 29, 630\u2013634 (1997).","journal-title":"J. Am. Coll. Cardiol."},{"key":"36153_CR16","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/j.jacc.2017.01.025","volume":"69","author":"AT Yan","year":"2017","unstructured":"Yan, A. T. et al. Association between cardiovascular risk factors and aortic stenosis: The CANHEART aortic stenosis study. J. Am. Coll. Cardiol. 69, 1523\u20131532 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"36153_CR17","first-page":"e521","volume":"129","author":"RA Nishimura","year":"2014","unstructured":"Nishimura, R. A. et al. 2014 AHA\/ACC guideline for the management of patients with valvular heart disease. Circulation 129, e521\u2013e643 (2014).","journal-title":"Circulation"},{"key":"36153_CR18","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","volume":"38","author":"H Baumgartner","year":"2017","unstructured":"Baumgartner, H. et al. 2017 ESC\/EACTS guidelines for the management of valvular heart disease. Eur. Heart J. 38, 2739\u20132791 (2017).","journal-title":"Eur. Heart J."},{"key":"36153_CR19","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"RM Lang","year":"2015","unstructured":"Lang, R. M. et al. Recommendations for chamber quantification: A Report from the American Society of Echocardiography\u2019s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology. J. Am. Soc. Echocardiogr. 18, 1440\u20131463 (2015).","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"36153_CR20","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1515\/CCLM.2010.046","volume":"48","author":"SM Hwang","year":"2010","unstructured":"Hwang, S. M. et al. Performance analysis of the ARCHITECT anti-cyclic citrullinated peptide antibody in the diagnosis of rheumatoid arthritis. Clin. Chem. Lab. Med. 48, 225\u2013230 (2010).","journal-title":"Clin. Chem. Lab. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36153-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36153-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36153-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T13:09:57Z","timestamp":1685624997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36153-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,1]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["36153"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-36153-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,1]]},"assertion":[{"value":"10 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8919"}}